View in EDS

Serum Markers as predictors for treatment benefit in castration-resistant prostate cancer.

Saved in:
Bibliographic Details
Title: Serum Markers as predictors for treatment benefit in castration-resistant prostate cancer.
Authors: Szarvas T; Department of Urology, Semmelweis University, Budapest, Hungary; Department of Urology, University of Duisburg-Essen, Essen, Germany., Kramer G; Department of Urology, Medical University of Vienna, Vienna, Austria., Jagarlamudi K; Department of Anatomy, Physiology and Biochemistry, Faculty of Veterinary Medicine and Animal Sciences, Biomedical Center, Swedish University of Agricultural Sciences, Uppsala, Sweden., Styrke J; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden., Linder S; Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. Electronic address: Stig.Linder@liu.se.
Source: Urologic oncology [Urol Oncol] 2025 Nov; Vol. 43 (11), pp. 664.e11-664.e17. Date of Electronic Publication: 2025 Aug 06.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 9805460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2496 (Electronic) Linking ISSN: 10781439 NLM ISO Abbreviation: Urol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40774833
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Serum Markers as predictors for treatment benefit in castration-resistant prostate cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Szarvas+T%22">Szarvas T</searchLink>; Department of Urology, Semmelweis University, Budapest, Hungary; Department of Urology, University of Duisburg-Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Kramer+G%22">Kramer G</searchLink>; Department of Urology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Jagarlamudi+K%22">Jagarlamudi K</searchLink>; Department of Anatomy, Physiology and Biochemistry, Faculty of Veterinary Medicine and Animal Sciences, Biomedical Center, Swedish University of Agricultural Sciences, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Styrke+J%22">Styrke J</searchLink>; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.<br /><searchLink fieldCode="AU" term="%22Linder+S%22">Linder S</searchLink>; Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. Electronic address: Stig.Linder@liu.se.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229805460%22">Urologic oncology</searchLink> [Urol Oncol] 2025 Nov; Vol. 43 (11), pp. 664.e11-664.e17. <i>Date of Electronic Publication: </i>2025 Aug 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9805460 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2496 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210781439%22">10781439 </searchLink><i>NLM ISO Abbreviation: </i>Urol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40774833
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.urolonc.2025.06.018
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 664.e11-664.e17
    Titles:
      – TitleFull: Serum Markers as predictors for treatment benefit in castration-resistant prostate cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Szarvas T
      – PersonEntity:
          Name:
            NameFull: Kramer G
      – PersonEntity:
          Name:
            NameFull: Jagarlamudi K
      – PersonEntity:
          Name:
            NameFull: Styrke J
      – PersonEntity:
          Name:
            NameFull: Linder S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2025 Nov
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1873-2496
          Numbering:
            – Type: volume
              Value: 43
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Urologic oncology
              Type: main
ResultId 1